If you've ever used an at-home genetic test, there is a chance your information is not as protected as you think it is. This week, California State Senator Tom Umberg introduced legislation to regulate the sharing of specimens collected through DNA analysis.
"What consumers don't know is the recipient of the specimen, those doing the analysis, may provide that to other entities," Umberg told Cheddar Friday. He said the new legislation will protect consumers and provide them the opportunity to make their own decisions about their data.
Illinois and New York have similar laws on the books. Illinois at the start of 2020 expanded protections for users of genetic testing kits like 23andMe and Ancestry.com
One of the concerns around the sharing of genetic testing is the disclosure of information that may have "health implications and insurance implications and maybe even employment implications," Umberg said. Tests can reveal a predisposition to a disease, information that, if sold to an entity like an insurance company, may affect the user beyond simply taking a test.
He said he became more concerned after the Department of Defense warned personnel not to use home DNA tests.
"If it's affecting national defense, I think consumers should know what's what that information is being used for," the legislator and retired U.S. Army colonel said.
The legislation Umberg introduced, California Senate Bill 980, provides for users to opt-in to letting companies pass on their information to third parties, like if the company offers some kind of compensation.
Walmart, which became the nation’s largest retailer by making low prices a priority, has found itself in a place it’s rarely been: Warning customers that prices will rise for goods ranging from bananas to car seats.
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!
Shan Aggarwal, VP of Corporate and Business Development at Coinbase, discusses the company's acquisitio of Deribit as it heads into the S&P 500. Watch!
American businesses that rely on Chinese goods are reacting with muted relief after the U.S. and China agreed to pause their exorbitant tariffs on each other’s products for 90 days. Many companies delayed or canceled orders after President Donald Trump last month put a 145% tariff on items made in China. Importers still face relatively high tariffs, however, as well as uncertainty over what will happen in the coming weeks and months. The temporary truce was announced as retailers and their suppliers are looking to finalize their plans and orders for the holiday shopping season. They’re concerned a mad scramble to get goods onto ships will lead to bottlenecks and increased shipping costs.
Shopping expert Trae Bodge discusses how talks between the U.S. and China is good news for now, but uncertainty remains for back-to-school and the holidays.
Jake Traylor, White House reporter at Politico, joins Cheddar to discuss how Trump is aiming to lower drug prices and how it differs from Biden's approach.
